No abstract available
MeSH terms
-
Adalimumab
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Certolizumab Pegol
-
Crohn Disease / drug therapy*
-
Crohn Disease / immunology
-
Drug Therapy, Combination
-
Gastrointestinal Agents / adverse effects
-
Gastrointestinal Agents / therapeutic use
-
Humans
-
Immunoglobulin Fab Fragments / adverse effects
-
Immunoglobulin Fab Fragments / therapeutic use
-
Immunologic Factors / adverse effects
-
Immunologic Factors / therapeutic use
-
Immunosuppressive Agents / therapeutic use
-
Infliximab
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Gastrointestinal Agents
-
Immunoglobulin Fab Fragments
-
Immunologic Factors
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Polyethylene Glycols
-
Infliximab
-
Adalimumab
-
Certolizumab Pegol